The Global Threat of Antibiotic Resistance
Published On Sep 26, 2024, 3:23 PM
International health experts are shifting their focus towards ensuring access to basic antibiotics in low-income countries to combat preventable deaths from infections. During a recent United Nations meeting, they emphasized that millions have never used antibiotics due to affordability issues, calling for measures like improved sanitation, vaccination, and better access to medications, rather than solely highlighting the problem of antimicrobial resistance.
Stock Forecasts
PFE
Positive
Pharmaceutical companies that produce antibiotics and vaccines may see an increased demand and focus as global health efforts prioritize accessibility; companies like Pfizer could benefit positively from this shift. Additionally, companies involved in health infrastructure in developing regions may also gain. However, antibiotic manufacturers might face scrutiny if they cannot balance production and responsible use, which could challenge their standing.
XLV
Positive
Investors should also consider healthcare ETFs such as the Health Care Select Sector SPDR Fund (XLV), which could see a positive impact as overall public health spending rises in response to global health initiatives.
Related News
Life spans are growing but 'health spans' are shrinking. What that means for your money
Oct 9, 2024, 9:52 AM
Older Americans are spending more years with chronic ailments, which often come with higher medical bills, experts said.
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specifics
Oct 8, 2024, 1:07 PM
Both have campaigned for lower prescription costs. Kamala Harris has promised to expand President Biden’s policies. Donald Trump is a wild card.
Stock market today: Dow tumbles 400 points, tech rout leads Nasdaq, S&P 500 lower as 10-year yield tops 4%
Oct 7, 2024, 4:04 PM
Investors have overhauled their views on interest rate cuts after a blowout jobs report, ahead of a week of key inflation data and the start of earnings season.